Home > Insider Trading > Filing (0000899243-22-030727)

Filing Details

Accession Number:: 0000899243-22-030727
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-09-09 16:14:02
Reporting Period:: 2022-09-08

Accepted Time:: 2022-09-09 16:14:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
730272	Repligen Corp	RGEN	Biological Products, (No Disgnostic Substances) (2836)	042729386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1606030	Anthony Hunt	C/O Repligen Corporation 41 Seyon St., Bldg 1, Ste 100 Waltham MA 02453	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-09-08	10,000	$33.87	204,667	No	4	M	Direct
Common Stock	Disposition	2022-09-08	824	$220.08	203,843	No	4	S	Direct
Common Stock	Disposition	2022-09-08	1,235	$221.46	202,608	No	4	S	Direct
Common Stock	Disposition	2022-09-08	720	$222.24	201,888	No	4	S	Direct
Common Stock	Disposition	2022-09-08	1,389	$223.26	200,499	No	4	S	Direct
Common Stock	Disposition	2022-09-08	6,626	$224.47	193,873	No	4	S	Direct
Common Stock	Disposition	2022-09-08	10,490	$225.22	183,383	No	4	S	Direct
Common Stock	Disposition	2022-09-08	4,873	$226.34	178,510	No	4	S	Direct
Common Stock	Disposition	2022-09-08	245	$227.01	178,265	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2022-09-08	10,000	$0.00	10,000	$33.87

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
59,246		2028-02-29	No	4	M	Direct

Footnotes

Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 14, 2021.
$220.08 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.42 to $220.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$221.46 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.86 to $221.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$222.24 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.87 to $222.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$223.26 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.90 to $223.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$224.47 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.91 to $224.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$225.22 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.91 to $225.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$226.34 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.94 to $226.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$227.01 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.98 to $227.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
This option is fully vested and exercisable.